Clinical Trial Results

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

PHASE1, PHASE2INTERVENTIONAL La Jolla, California +4 more

RECRUITING

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

NAINTERVENTIONAL Miami, Florida +4 more

RECRUITING

Childhood Cancer Survivor Study

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

N/AOBSERVATIONAL Dallas, Texas

RECRUITING

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

PHASE3INTERVENTIONAL Dallas, Texas

RECRUITING

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Metabolic Biomarkers in Thoracic Cancers

NAINTERVENTIONAL Dallas, Texas

RECRUITING

Project: Every Child for Younger Patients With Cancer

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

PHASE3INTERVENTIONAL La Jolla, California +4 more

RECRUITING

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery

PHASE2, PHASE3INTERVENTIONAL Dallas, Texas +3 more

RECRUITING

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

N/AOBSERVATIONAL Los Angeles, California +3 more

RECRUITING

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

N/AOBSERVATIONAL Long Beach, California +4 more

RECRUITING

Measuring Surgical Recovery After Radical Cystectomy

N/AOBSERVATIONAL Stanford, California +4 more

RECRUITING

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

PHASE3INTERVENTIONAL Loma Linda, California +4 more

RECRUITING

Dabrafenib and/or Trametinib Rollover Study

PHASE4INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

PHASE3INTERVENTIONAL Anchorage, Alaska +4 more

RECRUITING

Blue Light Cystoscopy With Cysview® Registry

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

The PREDICT Registry:

N/AOBSERVATIONAL Scottsdale, Arizona +4 more

RECRUITING

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

PHASE1INTERVENTIONAL Tucson, Arizona +4 more

RECRUITING

GammaPod Registry and Quality of Life Nomogram

N/AOBSERVATIONAL Bel Air, Maryland +3 more

RECRUITING